Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00329407 · ClinicalTrials.gov registry record · Phase 4
The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects
A Phase 4 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT00329407 is a Phase 4 study that has completed, run by Boston University. The registered enrollment target is 10 participants.
The verdict
NCT00329407, a Phase 4 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This investigation will assess the effectiveness of topiramate in reducing ethanol consumption by alcohol dependent subjects. It also will seek to establish whether topiramate can be safely used in this population including whether it might be subject to abuse by alcohol dependent individuals. A secondary goal of this study is to assess the effects of topiramate on verbal fluency during treatment for alcohol dependence.
Interventions
- DRUG Topiramate (Topamax)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00329407
The ClinicalTrials.gov registry entry for NCT00329407 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate (Topamax) is the first listed.
NCT00329407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00329407 about?
NCT00329407 is a clinical study titled "The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects". This investigation will assess the effectiveness of topiramate in reducing ethanol consumption by alcohol dependent subjects. It also will seek to establish whether topiramate can be safely used in this population including whether it might be subject to abuse by alcohol dependent individuals. A se...
What is the current status of trial NCT00329407?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2003-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00329407?
The interventions under investigation include: Topiramate (Topamax) (DRUG).
Who is sponsoring clinical trial NCT00329407?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.